Perrigo (PRGO)
(Real Time Quote from BATS)
$27.08 USD
+0.08 (0.30%)
Updated Jun 7, 2024 10:40 AM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Perrigo Company plc [PRGO]
Reports for Purchase
Showing records 341 - 360 ( 365 total )
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Ahead of 4Q12 - Hard To See Upside, But Momentum In Generics Makes It Even Harder to Bet Against.
Provider: CLAL FINANCE
Analyst: KREIZMAN J
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Weak Flu Season Dampens OTC Sales--Looking Forward to Easy Comparisons in FY13
Provider: CARIS & COMPANY
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
Mucinex ORx Launch and JNJ OTC Delays Support Improving CHC Sales
Provider: AURIGA USA
Analyst: CHEN L
Company: Perrigo Company plc
Industry: Medical - Products
Initiating with Buy and $125 Price Target
Provider: AURIGA USA
Company: Perrigo Company plc
Industry: Medical - Products
Getting Potentially Closer to Rx-to-OTC Switches of Some Major Drug Categories--Lipitor Could Come Soon
Provider: CARIS & COMPANY
Company: Perrigo Company plc
Industry: Medical - Products
Company: Perrigo Company plc
Industry: Medical - Products
New Products to Drive Sales Growth Acceleration in 2H12--No Change to EPS Estimates
Provider: CARIS & COMPANY